To further confirm whether the inhibition of miR-342-3p is a new therapeutic modality to control appetite and satiety in obesity, the experiments with neuron specific Mir342 knockout and transgenic mice, and direct injection of miR-342-3p mimic and antagomir are required. The gene discussed is MIR342; the disease is obesity disorder.